Clinical trial

AMAZE™ Asthma Implementation QI Study

NCT04901260

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-11-25

PhaseN/A

Study timeline

Study start (actual)2020-11-25Date precision: day

Registry last updated2022-08-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

AMAZE™ Disease Management PlatformDEVICE

Sponsors & collaborators

AstraZenecalead sponsor

Greater Austin Allergycollaborator

Evidera, Inc.collaborator

Mapped research locations

AustinTexas, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04901260 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.